71 – 80 of 133
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Gallium-68-labeled affibody molecule for PET imaging of PDGFRβ expression in vivo
- Contribution to journal › Article
-
Mark
Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule
- Contribution to journal › Article
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
(2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842
- Contribution to journal › Article
-
Mark
Incorporation of a triglutamyl spacer improves the biodistribution of synthetic affibody molecules radiofluorinated at the N-terminus via oxime formation with (18)F-4-fluorobenzaldehyde
- Contribution to journal › Article
-
Mark
Synthesis and biological evaluation of andrographolide analogues as anti-cancer agents
- Contribution to journal › Article
- 2013
-
Mark
Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors
- Contribution to journal › Article
-
Mark
Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility
- Contribution to journal › Article
-
Mark
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts
- Contribution to journal › Article
-
Mark
Arkadia regulates tumor metastasis by modulation of the TGF-β pathway
- Contribution to journal › Article
-
Mark
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer
- Contribution to journal › Article